Risk scores in ischaemic heart disease patients with type 2 diabetes, Isfahan, Iran

被引:1
|
作者
Maracy, Mohammad Reza [1 ]
Hossein, Sayed Mohsen [2 ]
Amini, Massoud [3 ]
机构
[1] Isfahan Univ Med Sci, Dept Community Med, Sch Med, Esfahan, Iran
[2] Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Esfahan, Iran
[3] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran
关键词
risk score; ischaemic heart disease; ROC curve; type; 2; diabetes;
D O I
10.2143/AC.63.6.2033390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The aim of this study was to determine a simple risk score for undiagnosed ischaemic heart disease (IHD) in patients with type 2 diabetes. Methods - A sample of 2 101 patients was taken from case records of diabetic patients held by the Isfahan Endocrine and Metabolism Research Centre outpatient clinic. The study was performed cross-sectionally. The following risk factors were analysed for developing a risk score among the patients: sex, age, duration of diabetes, body mass index, blood pressure, glycosylated haemoglobin, fasting blood sugar, cholesterol, triglycerides and smoking. A logistic regression model was used to compute the odds ratio (OR) for risk factors for diagnosed IHD. ORs of the models were used to assign a score value for each variable and the composite diabetes risk score was calculated as the sum of those scores. Results - 66% of patients were women and 36.8% patients had IHD. ROC curves were constructed to identify the optimum discriminator (>= 54 from 100) of diabetic patients for determining IHD. Sensitivity and specificity for predicting IHD were calculated for different cut-off scores. The sensitivity and specificity for IHD were around 64% and 57%, respectively. Conclusion - The present study focused on predicting ischaemic heart diseases in type 2 diabetes from factors that are easy to measure with non-invasive methods known to be associated with risk of IHD, using a risk score.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 50 条
  • [31] DIABETES AND ISCHAEMIC HEART DISEASE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1956, 2 (JUL7): : 36 - 37
  • [32] Adherence to Glyburide and Metformin and Associated Factors in Type 2 Diabetes in Isfahan, Iran
    Farsaei, Shall
    Sabzghabaee, Ali Mohammad
    Zargarzadeh, Amir Hooshang
    Amini, Massoud
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (04): : 933 - 939
  • [33] Gender difference in the relative risk of ischaemic heart disease in diabetes
    Hanna, FWF
    Currie, CJ
    Rees, A
    Peters, JR
    DIABETOLOGIA, 1996, 39 : 736 - 736
  • [34] Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran
    Janghorbani, Mohsen
    Amini, Masoud
    ENDOKRYNOLOGIA POLSKA, 2012, 63 (05) : 372 - 380
  • [35] Comparing distributions of polygenic risk scores of type 2 diabetes and coronary heart disease within different populations
    Reisberg, Sulev
    Iljasenko, Tatjana
    Lall, Kristi
    Fischer, Krista
    Vilo, Jaak
    PLOS ONE, 2017, 12 (07):
  • [36] Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle Intervention in Chronic lschaemic Heart Disease and Type 2 Diabetes study
    Dinges, Sophia M. T.
    Krotz, Janosch
    Gass, Felix
    Treitschke, Julian
    Fegers-Wustrow, Isabel
    Geisberger, Marisa
    Esefeld, Katrin
    von Korn, Pia
    Duvinage, Andre
    Edelmann, Frank
    Wolfram, Oliver
    Brandts, Julia
    Winzer, Ephraim B.
    Wolfarth, Bernd
    Freigang, Felix
    Neubauer, Sarah
    Nebling, Thomas
    Hackenberg, Bjorn
    Amelung, Volker
    Mueller, Stephan
    Halle, Martin
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (04):
  • [37] The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus
    van der Leeuw, J.
    van Dieren, S.
    Beulens, J. W. J.
    Boeing, H.
    Spijkerman, A. M. W.
    van der Graaf, Y.
    van der A, D. L.
    Noethlings, U.
    Visseren, F. L. J.
    Rutten, G. E. H. M.
    Moons, K. G. M.
    van der Schouw, Y. T.
    Peelen, L. M.
    HEART, 2015, 101 (03) : 222 - 229
  • [38] Socioeconomic status and ischaemic heart disease incidence in people with type 2 diabetes in Scotland
    Wild, S.
    Jones, N.
    McAllister, D.
    DIABETOLOGIA, 2012, 55 : S488 - S488
  • [39] A risk score for prediction of type 2 diabetes: the Isfahan Diabetes Prevention Study
    Amini, Masoud
    Janghorbani, Mohsen
    OBESITY AND METABOLISM-MILAN, 2009, 5 (01): : 13 - 19
  • [40] Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes
    Masi, Stefano
    D'Aiuto, Francesco
    Cooper, Jackie
    Salpea, Klelia
    Stephens, Jeffrey W.
    Hurel, Steven J.
    Deanfield, John E.
    Humphries, Steve E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 216 : 159 - 164